Category: Imaging & mpMRI

Focal therapy destroys a prostate tumor while leaving healthy tissue intact. But once treatment is done, how do doctors know if it worked? A structured follow-up protocol using mpMRI is the current standard. Now a newly proposed PSMA-based scoring system called PSMA-FAB is aiming to complement that approach. keep reading

A prostate MRI can detect cancer without contrast but how confident can a doctor be? DCE-MRI adds a third layer of information by capturing tumor blood flow patterns that plain MRI can't show. Gadolinium makes this possible, and modern formulations have an impressive safety record: over 170 million doses studied. keep reading

A high PSA result sounds alarming but it doesn't automatically mean cancer. Other factors can raise PSA, and until recently, the only way to know more was a biopsy. Now, two major breakthroughs are reshaping prostate cancer screening in ways that protect men from unnecessary procedures. keep reading

Multifocality has shaped prostate cancer treatment for years, but research shows some cases are unifocal and may qualify for less invasive focal therapy. Careful clinical evaluation is key to tailoring the best treatment approach. keep reading

Traditional PSA screening can lead to overdetection and unnecessary biopsies due to its lack of specificity for prostate cancer. New research highlights biparametric MRI as a promising, quicker, and potentially more accurate first-line screening tool. keep reading

Imagine seeing even clearer prostate images than today’s advanced 3T MRI allows—5T MRI could make that a reality. While research teams report remarkable image quality and better tumor visibility with 5T, economic and practical challenges mean that 3T MRI remains the standard for prostate cancer screening and treatment guidance. keep reading

What if a computer could spot key signs of prostate cancer on MRI scans just as well as a seasoned radiologist—or even better? As thousands of new prostate MRIs need expert reading each year, artificial intelligence is stepping in with data-driven precision, promising to sharpen diagnostic accuracy and lighten the load for busy professionals. keep reading

PET/MRI combines advanced imaging techniques for superior detection of aggressive and recurrent prostate cancer, offering detailed views and lower radiation exposure compared to PET/CT. It's especially valuable for complex cases and can help avoid unnecessary biopsies. keep reading

Whole Body MRI and PSMA PET-CT scans each offer unique insights into advanced prostate cancer. Discover how these imaging methods compare in finding cancer spread beyond the prostate gland. keep reading

Artificial Intelligence is reshaping prostate cancer care, from more accurate screening and early detection to optimizing treatment strategies. New research highlights four major clinical areas where AI is already making a measurable difference in diagnosis, risk assessment, and therapy planning. keep reading